HERB yields 12500.00% · JNJ yields 2.14%● Live data
📍 HERB pulled ahead of the other in Year 1
Combined, HERB + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HERB + JNJ for your $10,000?
YaSheng Group, through its subsidiaries, designs, develops, manufactures, and markets farming and sideline products; chemical materials and products; textiles; construction materials; and livestock and poultry products primarily in the People's Republic of China. It cultivates, processes, markets, and distributes various food and agro-byproducts. The company's products include cotton, corns, barley, wheat, flax, and alfalfa; vegetables comprising onions, potatoes, beet, and peas; fruits, including apples, pears, and apricots; specialty crops consisting of hops, wolfberries, cumin, hemp, and liquorices; seeds, such as black melon, sunflower, corn, hemp, and flax seeds; and eggs. It also provides construction materials, such as cement; and designs, develops, and markets new technologies related to agriculture and genetic biology. The company sells its products to food processors, supermarkets, and wholesale stores through distributors, as well as to direct customers. YaSheng Group exports its products. The company was founded in 1998 and is based in Lanzhou, the People's Republic of China. As of December 31, 2015, YaSheng Group is a subsidiary of Gansu Yasheng Salt Chemical Industrial Group, Ltd.
Full HERB Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.